FOSL vs GILD · rev $434.4M vs P/E 18, rev $7.80B
Fossil Group Inc (FOSL) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Fossil Group Inc (FOSL) is a footwear & accessories company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported FOSL revenue for 2026-07-04 was $434.4M. Net income was -$11.3M. Revenue was up 93.3% from 2026-04-04 to 2026-07-04. FOSL currently screens at market cap $248.2M.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
FOSL currently screens at market cap $248.2M. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the FOSL and GILD stock pages for the full models.
Not investment advice.